- Home
- PRPO vs NUKK Comparison
PRPO vs NUKK Comparison
Compare PRPO & NUKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- NUKK
- Stock Information
- Founded
- PRPO N/A
- NUKK 2013
- Country
- PRPO United States
- NUKK United States
- Employees
- PRPO N/A
- NUKK N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- NUKK Blank Checks
- Sector
- PRPO Industrials
- NUKK Finance
- Exchange
- PRPO Nasdaq
- NUKK Nasdaq
- Market Cap
- PRPO 22.0M
- NUKK 25.4M
- IPO Year
- PRPO N/A
- NUKK N/A
- Fundamental
- Price
- PRPO $17.59
- NUKK $5.75
- Analyst Decision
- PRPO
- NUKK
- Analyst Count
- PRPO 0
- NUKK 0
- Target Price
- PRPO N/A
- NUKK N/A
- AVG Volume (30 Days)
- PRPO 16.8K
- NUKK 11.5M
- Earning Date
- PRPO 11-05-2025
- NUKK 11-14-2025
- Dividend Yield
- PRPO N/A
- NUKK N/A
- EPS Growth
- PRPO N/A
- NUKK N/A
- EPS
- PRPO N/A
- NUKK N/A
- Revenue
- PRPO $21,242,000.00
- NUKK N/A
- Revenue This Year
- PRPO N/A
- NUKK N/A
- Revenue Next Year
- PRPO N/A
- NUKK N/A
- P/E Ratio
- PRPO N/A
- NUKK N/A
- Revenue Growth
- PRPO 27.05
- NUKK N/A
- 52 Week Low
- PRPO $3.90
- NUKK $1.30
- 52 Week High
- PRPO $22.38
- NUKK $78.32
- Technical
- Relative Strength Index (RSI)
- PRPO 54.11
- NUKK 55.82
- Support Level
- PRPO $17.00
- NUKK $5.15
- Resistance Level
- PRPO $22.38
- NUKK $6.66
- Average True Range (ATR)
- PRPO 1.35
- NUKK 0.75
- MACD
- PRPO -0.13
- NUKK 0.24
- Stochastic Oscillator
- PRPO 40.83
- NUKK 50.93
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About NUKK Nukkleus Inc.
Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).